Over 70% Repigmentation Achieved In Patients With Stable Vitiligo
Main Category: DermatologyAlso Included In: Clinical Trials / Drug Trials
Article Date: 26 Apr 2006 - 0:00 PDT
| Patient / Public: | ![]() |
3.67 (3 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
A high percentage of repigmentation is achieved in patients with stable vitiligo by noncultured epidermal cell transplantation, according to both subjective and objective evaluation methods.
In this soon to be published study in the journal "Dermatology", noncultured autologous melanocytes and keratinocytes were grafted in a hyaluronic-acid-enriched suspension on superficially laser-abraded vitiligo lesions in 40 patients with refractory stable vitiligo.
The repigmentation was evaluated 3-12 months after grafting using a digital image analysis system. Furthermore, the treatment was evaluated from the patients' point of view with the Dermatology Life Quality Index and a global assessment.
The mean percentage of repigmentation at the last follow-up visit was 72%; a repigmentation of more than 70% was observed in 62% of the patients. The best results were achieved in the neck and presternal regions.
All patients were satisfied with the achieved results, found it worthwhile to undergo the treatment and would choose to do so again.
About the S. KARGER AG
With over a century of experience in connecting the world of biomedical science, Karger publishes nearly 80 scientific, peer-reviewed journals and 150 serial and non-serial books and supplement issues annually for a global scientific readership.
http://www.karger.com
Visit our dermatology section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/42222.php>
APA
http://www.medicalnewstoday.com/releases/42222.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




